Insmed's Q3 Loss Wider Than Expected, Sales In Line With Estimates

Insmed (INSM) reported a third-quarter 2024 loss of $1.27 per share, wider than the Zacks Consensus Estimate of a loss of$1.19. In the year-ago quarter, the company posted a loss of $1.11 per share.Insmed generated total revenues of$93.4 million during the quarter, up 18% year over year. Quarterly sales were in line with the Zacks Consensus Estimate.Shares of INSM were down more than 4% on Thursday likely due to the earnings miss.See the Zacks Earnings Calendar to stay ahead of market-making news.Year to ...